Epimedium Prenylflavonoid (EP) Extract for Osteoporosis and Cardiovascular Disease

Conditions:   Osteoporosis;   Cardiovascular Disease Interventions:   Drug: Epimedium Prenylflavonoids Extract;   Drug: Placebo Sponsor:   National University Hospital, Singapore Recruiting - verified October 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials